Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
作者信息
Folkman J
机构信息
Departments of Surgery and Cellular Biology, Harvard Medical School and Children's Hospital, Boston, MA 02115, USA.
出版信息
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):398-400. doi: 10.1073/pnas.98.2.398.
Abstract
摘要
相似文献
1
Can mosaic tumor vessels facilitate molecular diagnosis of cancer?镶嵌状肿瘤血管能否促进癌症的分子诊断？
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):398-400. doi: 10.1073/pnas.98.2.398.
2
Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?血管和造血干细胞：抗血管生成治疗的新靶点？
Nat Rev Cancer. 2002 Nov;2(11):826-35. doi: 10.1038/nrc925.
3
Tumoral vascularity as a prognostic factor in cancer.肿瘤血管生成作为癌症的一个预后因素。
Important Adv Oncol. 1996:167-90.
4
Angiogenesis in multiple myeloma.多发性骨髓瘤中的血管生成
Leuk Res. 2002 Jul;26(7):701-2. doi: 10.1016/s0145-2126(01)00168-0.
5
Cancer: Limitations of therapies exposed.癌症：已暴露的治疗局限性。
Nature. 2012 Apr 4;484(7392):44-6. doi: 10.1038/484044a.
6
[Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].[血管内皮生长因子——VEGF——在肿瘤血管生成中的意义。实体瘤的治疗可能性]
Ugeskr Laeger. 2000 Sep 11;162(37):4916-20.
7
Vascular endothelial growth factor as a target for antiangiogenic therapy.血管内皮生长因子作为抗血管生成治疗的靶点。
J Clin Oncol. 2000 Nov 1;18(21 Suppl):45S-6S.
8
[Tumor angiogenesis].[肿瘤血管生成]
Seikagaku. 1998 Sep;70(9):1159-70.
9
Anticancer therapy with angiogenesis inhibitors.使用血管生成抑制剂的抗癌疗法。
Tumori. 2001 Nov-Dec;87(6):S14-6.
10
Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.血管生成、抗血管生成及血管靶向治疗的最新进展
Trends Pharmacol Sci. 2002 Dec;23(12):576-82. doi: 10.1016/s0165-6147(02)02109-0.
引用本文的文献
1
Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens.治疗性癌症疫苗与肿瘤微环境之间的双向串扰：超越肿瘤抗原
Fundam Res. 2022 Mar 26;3(6):1005-1024. doi: 10.1016/j.fmre.2022.03.009. eCollection 2023 Nov.
2
The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer.癌症中pH值失调与电解质失衡的相互作用
Cancers (Basel). 2020 Apr 7;12(4):898. doi: 10.3390/cancers12040898.
3
Vasculogenic Mimicry: A Promising Prognosticator in Head and Neck Squamous Cell Carcinoma and Esophageal Cancer? A Systematic Review and Meta-Analysis.血管生成拟态：头颈部鳞状细胞癌和食管癌中有前途的预后指标？系统评价和荟萃分析。
Cells. 2020 Feb 24;9(2):507. doi: 10.3390/cells9020507.
4
Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.调整纳米粒子的脂质组成可以调节其细胞摄取，并影响三阴性乳腺癌细胞的活力。
J Control Release. 2019 Aug 10;307:331-341. doi: 10.1016/j.jconrel.2019.06.025. Epub 2019 Jun 22.
5
Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.碳酸氢钠纳米颗粒调节肿瘤 pH 值并增强阿霉素的细胞摄取。
J Control Release. 2019 Feb 28;296:1-13. doi: 10.1016/j.jconrel.2019.01.004. Epub 2019 Jan 5.
6
Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapy.葡萄糖限制诱导亲本 RKO 结肠癌细胞死亡，但不会诱导同源结构域相互作用蛋白激酶 2 耗竭的 RKO 结肠癌细胞死亡：分子机制及其对肿瘤治疗的意义。
Cell Death Dis. 2013 May 23;4(5):e639. doi: 10.1038/cddis.2013.163.
7
Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.节拍化疗联合抗血管生成治疗诱导肝癌异种移植瘤马赛克血管减少和肿瘤生长抑制。
J Cancer Res Clin Oncol. 2012 Nov;138(11):1879-90. doi: 10.1007/s00432-012-1270-7. Epub 2012 Jun 27.
8
Targeting the tumor microenvironment: focus on angiogenesis.靶向肿瘤微环境：关注血管生成。
J Oncol. 2012;2012:281261. doi: 10.1155/2012/281261. Epub 2011 Aug 24.
9
Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.肝细胞癌中模式化基质血管生成拟态的预后意义和机制。
Med Oncol. 2011 Dec;28 Suppl 1:S228-38. doi: 10.1007/s12032-010-9706-x. Epub 2010 Oct 19.
10
Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.神经胶质瘤干细胞/祖细胞通过转分化促进血管生成。
Stem Cell Rev Rep. 2011 Mar;7(1):141-52. doi: 10.1007/s12015-010-9169-7.
本文引用的文献
1
Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood.肿瘤中的镶嵌血管：与流动血液接触的癌细胞频率
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14608-13. doi: 10.1073/pnas.97.26.14608.
2
Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells.人毛细血管内皮细胞中基质金属蛋白酶-2激活的黏附依赖性调控
J Cell Sci. 2000 Nov;113 ( Pt 22):3979-87. doi: 10.1242/jcs.113.22.3979.
3
4
Tech.sight. Genetic testing--present and future.科技视野。基因检测——现状与未来。
Science. 2000 Sep 15;289(5486):1890-2. doi: 10.1126/science.289.5486.1890.
5
Angiogenesis in cancer and other diseases.癌症及其他疾病中的血管生成。
Nature. 2000 Sep 14;407(6801):249-57. doi: 10.1038/35025220.
6
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.化疗的抗血管生成给药方案可提高对实验性耐药癌症的疗效。
Cancer Res. 2000 Apr 1;60(7):1878-86.
7
Openings between defective endothelial cells explain tumor vessel leakiness.有缺陷的内皮细胞之间的开口解释了肿瘤血管的渗漏。
Am J Pathol. 2000 Apr;156(4):1363-80. doi: 10.1016/S0002-9440(10)65006-7.
8
Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.血小板反应蛋白-2：一种强大的肿瘤生长和血管生成内源性抑制剂。
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14888-93. doi: 10.1073/pnas.96.26.14888.
9
Endothelial progenitor cells as putative targets for angiostatin.内皮祖细胞作为血管抑素的假定靶点。
Cancer Res. 1999 Dec 1;59(23):5875-7.
10
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.Id1和Id3是肿瘤异种移植的神经发生、血管生成和血管化所必需的。
Nature. 1999 Oct 14;401(6754):670-7. doi: 10.1038/44334.
Zotero 插件